These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 23052429)

  • 41. Paradoxical psoriasiform reactions of anti-tumour necrosis factor therapy in inflammatory bowel disease patients.
    Peer FC; Miller A; Pavli P; Subramaniam K
    Intern Med J; 2017 Dec; 47(12):1445-1448. PubMed ID: 29224199
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy and safety of adalimumab in patients with psoriasis previously treated with anti-tumour necrosis factor agents: subanalysis of BELIEVE.
    Ortonne JP; Chimenti S; Reich K; Gniadecki R; Sprøgel P; Unnebrink K; Kupper H; Goldblum O; Thaçi D
    J Eur Acad Dermatol Venereol; 2011 Sep; 25(9):1012-20. PubMed ID: 21214631
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Drug-induced psoriasiform alopecia associated with interleukin-17 inhibitor therapy.
    Tan TL; Taglia L; Yazdan P
    J Cutan Pathol; 2021 Jun; 48(6):771-774. PubMed ID: 33389767
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Flexural psoriasis induced by infliximab and adalimumab in a patient with Crohn's disease].
    Avila Alvarez A; García-Alonso L; Solar Boga A; García-Silva J
    An Pediatr (Barc); 2009 Mar; 70(3):278-81. PubMed ID: 19409245
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Psoriasiform eruptions during anti TNF-alpha treatment: psoriasis or not?
    Seneschal J; Lepreux S; Milpied B; Schaeverbeke T; Taïeb A
    Arch Dermatol; 2007 Dec; 143(12):1593-5; author reply 1595. PubMed ID: 18087021
    [No Abstract]   [Full Text] [Related]  

  • 46. Anti TNF-α in refractory Takayasu's arteritis: cases series and review of the literature.
    Comarmond C; Plaisier E; Dahan K; Mirault T; Emmerich J; Amoura Z; Cacoub P; Saadoun D
    Autoimmun Rev; 2012 Jul; 11(9):678-84. PubMed ID: 22155781
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alopecia areata during treatment of psoriasis with adalimumab and leflunomide: a case and review of the literature.
    Navarro R; Daudén E; Gallo E; Santiago Sánchez-Mateos D; García-Diez A
    Skin Pharmacol Physiol; 2012; 25(2):107-10. PubMed ID: 22301842
    [TBL] [Abstract][Full Text] [Related]  

  • 48. TNF-inhibitor associated psoriatic alopecia: Diagnostic utility of sebaceous lobule atrophy.
    Afanasiev OK; Zhang CZ; Ruhoy SM
    J Cutan Pathol; 2017 Jun; 44(6):563-569. PubMed ID: 28332233
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tumor necrosis factor-induced alopecia: alternative pathology and therapy.
    Udkoff J; Cohen PR
    Dermatol Online J; 2017 Jun; 23(6):. PubMed ID: 28633753
    [TBL] [Abstract][Full Text] [Related]  

  • 50. New-onset psoriatic palmoplantaris pustulosis following infliximab therapy: a class effect?
    Roux CH; Brocq O; Leccia N; Giacchero D; Breuil V; Albert C; Lacour J; Perrin C; Euller-Ziegler L
    J Rheumatol; 2007 Feb; 34(2):434-7. PubMed ID: 17295430
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tumour necrosis factor-α antagonists in patients with concurrent psoriasis and hepatitis B or hepatitis C: a retrospective analysis of 17 patients.
    Prignano F; Ricceri F; Pescitelli L; Zanieri F; Lotti T
    Br J Dermatol; 2011 Mar; 164(3):645-7. PubMed ID: 21375517
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anti-TNF-alpha therapy for orofacial granulomatosis: proceed with caution.
    Gaya DR; Aitken S; Fennell J; Satsangi J; Shand AG
    Gut; 2006 Oct; 55(10):1524-5. PubMed ID: 16966709
    [No Abstract]   [Full Text] [Related]  

  • 53. Analysis of anti-tumour necrosis factor-induced skin lesions reveals strong T helper 1 activation with some distinct immunological characteristics.
    Stoffel E; Maier H; Riedl E; Brüggen MC; Reininger B; Schaschinger M; Bangert C; Guenova E; Stingl G; Brunner PM
    Br J Dermatol; 2018 May; 178(5):1151-1162. PubMed ID: 29143979
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acneiform eruption following anti-TNF-alpha treatment: a report of three cases.
    Sun G; Wasko CA; Hsu S
    J Drugs Dermatol; 2008 Jan; 7(1):69-71. PubMed ID: 18246701
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comments on 'Generalized erythroderma and palmoplantar hyperkeratosis in a patient receiving TNF-alpha antagonist therapy'.
    Martinez-Escala ME; Guitart J
    J Cutan Pathol; 2015 Apr; 42(4):295-6. PubMed ID: 25354264
    [No Abstract]   [Full Text] [Related]  

  • 56. Onset of psoriasis in patients with inflammatory bowel disease treated with anti-TNF agents.
    Guerra I; Gisbert JP
    Expert Rev Gastroenterol Hepatol; 2013 Jan; 7(1):41-8. PubMed ID: 23265148
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Psoriasis induced by a TNF-alpha antagonist in a patient with ulcerative colitis].
    Machado RI; Souto LM; Freire EA
    Acta Gastroenterol Latinoam; 2012 Dec; 42(4):325-8. PubMed ID: 23383527
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Palmoplantar and scalp psoriasis occurring during anti-tumour necrosis factor-alpha therapy: a case series of four patients and guidelines for management.
    Papadavid E; Gazi S; Dalamaga M; Stavrianeas N; Ntelis V
    J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):380-2. PubMed ID: 18269613
    [No Abstract]   [Full Text] [Related]  

  • 59. Use of anti-tumor necrosis factor-α therapy in hepatitis B virus carriers with psoriasis or psoriatic arthritis: a case series in Taiwan.
    Cho YT; Chen CH; Chiu HY; Tsai TF
    J Dermatol; 2012 Mar; 39(3):269-73. PubMed ID: 22077677
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Paradoxical Psoriasiform Eruptions in Children Receiving Tumor Necrosis Factor α Inhibitors.
    Eickstaedt J; Paller AS; Lund E; Murphrey M; Brandling-Bennett H; Maurano M; Fernandez Faith E; Holland KE; Ibler E; Liang MG; Todd PS; Siegfried E; Igelman S; Cordoro KM; Tollefson MM
    JAMA Dermatol; 2023 Jun; 159(6):637-642. PubMed ID: 37043214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.